Graviton Bioscience, a privately held clinical-stage biotechnology company focused on therapies that inhibit Rho/Rho-associated coiled-coil containing protein kinase 2 (ROCK2), along with other therapeutic compounds.
Company Details
- Employees
- 47
- Founded
- -
- Address
- 125 West End Ave,
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.gravitoncorp.com
- Keywords
- Gurugram.
- HQ
- New York, New York
Graviton Bioscience Questions
Graviton Bioscience's website is http://www.gravitoncorp.com
Graviton Bioscience's LinkedIn profile is https://www.linkedin.com/company/graviton-bioscience
Graviton Bioscience has
47 employees.
View email and phone details for 47
employees at Graviton Bioscience.
Graviton Bioscience's industry is
Biotechnology Research
Graviton Bioscience's top competitors are
Complement Pharma,
Meiragtx,
Geneva,
Équilibre Biopharmaceuticals Corp.,
West End Labs,
Graviton Research Capital Llp,
Grafton Biosciences,
Ovid Therapeutics,
Andreessen Horowitz,
Nucleate New York.
Graviton Bioscience's categories are Biotechnology Research
Graviton Bioscience's founding year is 2023
